NCT02532309 - A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques | Biotech Hunter

Enrollment

308

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2018

Conditions

Carotid Atherosclerosis

Interventions

DRUG

Rosuvastatin (5mg，10mg，20mg)

Rosuvastatin dose adjusted by LDL-c level( If LDL-C\>1.1mmol/L and \<1.8mmol/L, administrated as 5mg/day.If LDL-C ≥1.8mmol/L, adjusted every 4 weeks as 5mg，10mg，20mg.

DRUG

Rosuvastatin 5mg

Rosuvastatin 5mg/day

Trial Locations (1)

Unknown

RECRUITING

China-Japan Friendship Hospital, Beijing